"Industry-Sponsored Research" Resources

            1. Jill A. Fisher, “Practicing Research Ethics: Private-Sector Physicians & Pharmaceutical Clinical Trials,” Social Science & Medicine (1982), 2008, 66(12), pp. 2495–2505. http://doi.org/10.1016/j.socscimed.2008.02.001

 

            2. Trudo Lemmens, “Conflict of Interest in Medical Research: Historical Developments,” in The Oxford Textbook of Clinical Research Ethics, ed. Ezekiel Emanuel et al. (New York: Oxford University Press, 2008), pp. 747-57.

 

            3. Trudo Lemmens, “Conflict of Interest in Medical Research: Historical Developments.”

 

            4. Miriam Shuchman, “Commercializing Clinical Trials -- Risks and Benefits of the CRO Boom,” The New England Journal of Medicine, Vol. 357, No. 14 (Oct 4, 2007), pp. 1365-8.

 

            5. Jason E. Klein and Alan R. Fleischman, “The Private Practicing Physician-Investigator: Ethical Implications of Clinical Research in the Office Setting,” The Hastings Center Report, Vol. 32, No. 4 (Jul. - Aug., 2002), pp. 22-26.

URL: http://www.jstor.org/stable/3528085

 

            6. Lois Snyder and Paul S. Mueller, “Research in the Physician’s Office: Navigating the Ethical Minefield,” Hastings Center Report, Vol. 38, No. 2 (2008), pp. 23-25.

 

            7. J. S. Ross, C.P. Gross, & H.M. Krumholz, “Promoting Transparency in Pharmaceutical Industry–Sponsored Research,” American Journal of Public Health, Vol. 102, No. 1 (2012), pp. 72–80. http://doi.org/10.2105/AJPH.2011.300187

 

            8. Lemmens, “Conflict of Interest in Medical Research,” 748.

 

            9. Lemmens, “Conflict of Interest in Medical Research,” 749.

 

            10. Adam G. Dunn et al., “Conflict of Interest Disclosure in Biomedical Research: A Review of Current Practices, Biases, and the Role of Public Registries in Improving Transparency,” Research Integrity and Peer Review, Vol. 1, No. 1 (2016), pp. 1-8. DOI 10.1186/s41073-016-0006-7

 

            11. Joanne Waldstreicher and Michael Johns, “Managing Conflicts of Interest in Industry-Sponsored Clinical Research: More Physician Engagement is Required,” Journal of the American Medical Association, Vol. 317, No. 17 (May 2, 2017), pp. 1751-1752.

 

            12. Ross et al., “Promoting Transparency.”

 

            13. Bernard Lo and Marilyn J. Field, eds., Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice, Conflict of Interest in Medical Research, Education, and Practice (Washington, DC: National Academies Press [US], 2009). Available from: https://www.ncbi.nlm.nih.gov/books/NBK22942/ doi: 10.17226/12598

 

            14. Waldstreicher and John, “Managing Conflicts of Interest.”

 

            15. Pharmaceutical Research and Manufacturers of America (PhRMA), PhRMA Principles on Conduct of Clinical Trials. PhRMA website. http://www.phrma .org/codes-and-guidelines/phrma-principles-on -conduct-of-clinical-trials.

 

            16. Klein and Fleischman, ““The Private Practicing Physician-Investigator.”

 

            17. Fisher, ““Practicing Research Ethics.”

 

            18. Fisher, ““Practicing Research Ethics.”

 

            19. Emanuel Ezekiel and Dennis Thompson, “The Concept of Conflicts of Interest,” in The Oxford Textbook of Clinical Research Ethics, ed. Emanuel, Ezekiel et al. (New York: Oxford University Press, 2008), pp. 758-66.

 

            20. Department of Health and Human Services, Office of the Inspector General, Recruiting Human Subjects: Pressures in Industry-sponsored Clinical Research, Washington, D.C.: Department of Health and Human Services, June 2000; OE1-01-97-00195.

 

            21. Klein and Fleischman, ““The Private Practicing Physician-Investigator.”

 

            22. Edmund Pellegrino and David Thomasma, “The Healing Relationship: The Architechtonics of Clinical Medicine,” from A Philosophical Basis of Medical Practice: Toward a Philosophy and Ethic of the Healing Professions, (New York: Oxford University Press, 1981), pp. 80-94.

            23. Matthew Wynia and David Boren, “Better regulation of industry-sponsored clinical trials is long overdue,” Journal of Law, Medicine and Ethics, from Symposium: Dangerous Liaisons? Industry Relations with Health Professionals (Fall 2009), pp. 410-419.

           

24. J. Sotelo, “Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal,” PLOS Medicine Vol. 3, No. 7, e306 (July 2006), pp. 945-47. https://doi.org/10.1371/journal.pmed.0030306

 

25. Joel Lexchin et al., “Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review,” British Medical Journal, Vol. 326, No. 1167 (May 2003), pp. 1-10. doi: https://doi.org/10.1136/bmj.326.7400.1167 

            26. Dunn et al., “Conflict of Interest Disclosure in Biomedical Research.”

CONTACT

To learn more about the LMU Bioethics Institute click below.  

LMU Bioethics Institute

Loyola Marymount University Suite 4500

1 LMU Drive

Los Angeles, CA 90045

lmu.edu/bioethics

Tel: 310-258-5417

If you have a bioethics-related event or opportunity you would like featured in our calendar, contact the Bioethics Institute Graduate Assistant, at BioethicsGA@lmu.edu, with relevant information.

© Graduate Students of the LMU Bioethics Institute

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey YouTube Icon